Rimonabant hydrochloride

1 1

Selleck Chemicals

E4858-5MG

€193,00 EUR
€193,00 EUR
Sale Sold out
Shipping calculated at checkout.
Size
View full details

Rimonabant hydrochloride is an antagonist of Cannabinoid Receptors used in studies of GPCR Signaling. In practice, this places the compound in experiments that measure receptor-driven second-messenger signaling and desensitization dynamics in cardiovascular and neuroscience models.

By blocking Cannabinoid Receptors, Rimonabant hydrochloride can be used to examine receptor-driven second-messenger signaling and desensitization dynamics. The gpcr annotation adds relevance to GPCR pharmacology, ligand-binding, and signaling assays, together with downstream-response mapping in the same experimental setting. In cardiovascular and neuroscience models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

  • Target-focused assays involving Cannabinoid Receptors
  • Pathway perturbation studies connected to GPCR Signaling
  • Receptor-blockade and ligand-competition studies
  • GPCR pharmacology, ligand-binding, and signaling assays

Overall, Rimonabant hydrochloride is appropriate when a defined chemical perturbant is needed to connect Cannabinoid Receptors with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in cardiovascular and neuroscience models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.

Targets:
Cannabinoid Receptors
Target Class:
GPCR
Pathways:
GPCR Signaling
Research Area:
Cardiovascular • Neuroscience
CAS No.:
158681-13-1
Molecular Weight:
500.25
Formula:
C₂₂H₂₁Cl₃N₄O·ClH
Storage Temperature:
-20°C

For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.

The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.